Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00211731
Status:
COMPLETED
Last Update Posted:
2014-11-11
First Post:
2005-09-13
Brief Title:
Preventing Recurrent Stroke in Minority Populations
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Icahn School of Medicine at Mount Sinai
Study Overview
Official Title:
Improving the Delivery of Effective Care to Minorities
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study focuses on causes of under-use of secondary stroke preventive measures demonstrated in randomized clinical trials to be efficacious but not appropriately utilized in urban minority populations
Detailed Description:
As the population ages and the number of prevalent strokes increases recurrent stroke is becoming an increasingly important health care burden National and local data strongly suggest that this burden falls disproportionately on minority populations notably Blacks and Hispanics This study seeks to determine the factors that contribute to that disparity and design and implement a novel intervention tailored to alleviate the factors identified Specifically it will focus on causes of under-use of stroke preventive measures demonstrated in randomized clinical trials to be efficacious but not appropriately utilized in urban minority populations
In the first phase of the study charts of acute stroke patients in 4 large urban hospitals that serve the 3 racialethnic groups under study Blacks Hispanics and non-Hispanic whites will be reviewed to determine the magnitude of under-use of these measures Simultaneously a panel of local expert physicians will finalize the proposed criteria for appropriate attention to risk factor assessment and modification In the second phase of the proposed work we will conduct a randomized trial intervention strategy that will include a control arm and a patient educational arm where participants will be enrolled in a Chronic Disease Self Management Program The program is designed to teach patients tools for managing their chronic illness which will empower them to improve their overall health The program will be specifically tailored for patients living with asymptomatic chronic illnesses and will emphasize communication with health care providers The educational intervention will be accompanied by a two-phased chart abstraction to measure clinical markers pre and post intervention In the final phase of the study the results of the trial will be analyzed and the results disseminated
In the first phase of the study charts of acute stroke patients in 4 large urban hospitals that serve the 3 racialethnic groups under study Blacks Hispanics and non-Hispanic whites will be reviewed to determine the magnitude of under-use of these measures Simultaneously a panel of local expert physicians will finalize the proposed criteria for appropriate attention to risk factor assessment and modification In the second phase of the proposed work we will conduct a randomized trial intervention strategy that will include a control arm and a patient educational arm where participants will be enrolled in a Chronic Disease Self Management Program The program is designed to teach patients tools for managing their chronic illness which will empower them to improve their overall health The program will be specifically tailored for patients living with asymptomatic chronic illnesses and will emphasize communication with health care providers The educational intervention will be accompanied by a two-phased chart abstraction to measure clinical markers pre and post intervention In the final phase of the study the results of the trial will be analyzed and the results disseminated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P01HS010859-05 | AHRQ | None | httpsreporternihgovquickSearchP01HS010859-05 |